SCHEMBL528406

SCHEMBL528406

CCCc1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)cc2c1Nc1ccc(CN(C)C)cc1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MELK Q14680 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL529146 0.95 MELK (0.75) MELK
SCHEMBL529410 0.95 MELK (0.71) MELK
SCHEMBL529566 0.92 MELK (0.76) MELK
SCHEMBL12505172 0.90 MELK (0.73) MELK
SCHEMBL529199 0.88 MELK (0.75) MELK
SCHEMBL529157 0.87 MELK (0.74) MELK
SCHEMBL12504816 0.87 MELK (0.72) MELK
SCHEMBL17434862 0.85 MELK (0.79) MELK
SCHEMBL17434960 0.85 MELK (0.70) MELK
SCHEMBL10281978 0.85 MELK (1.00) MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2597955-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME OncoTherapy Science, Inc. (JP) 2013-06-05 EP disclosed
WO-2012016082-A1 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2012-02-02 WO disclosed